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This thesis was carried out with the collaboration of DelSiTech Ltd, which is a leading 
silica-based drug delivery technology and drug development company based in Finland. 
In the beginning of this study, spray dried silica gel microparticles, used as a carrier ma-
terial for therapeutic agents, were mixed together with a sol-gel derived silica sol. It was 
paramount that the mixing was performed before the initial silica sol had been allowed to 
form a hydrogel. This ensured the creation of a homogenous mixture. In the end, the 
mixture was filled into syringes and allowed to form a stable and injectable silica micro-
particle-silica hydrogel composite product.  
The continuous hydrogel matrix of the composite elicits excellent shear-thinning charac-
teristics, and as a result, could facilitate the parenteral administration of therapeutic agents 
encapsulated within the silica microparticles. Throughout the study, the formulation of 
the sol-gel derived silica sol was kept constant at an R-value of 400 (molar ratio of water 
to silica alkoxide). In contrast, the volume concentration of silica microparticles ranged 
from 0.5 to 1 g/ml, which was noticed to affect the gelation rate of the silica-silica com-
posite. This indicated that the microparticles act as nucleating agents in the formation of 
the three-dimensional gel structure.       
In order to optimize the manufacturing process of the composite and to define the ap-
plicability of the final product, three objectives were set: determine the time-frame in 
which to mix the composite as well as fill the syringes, evaluate the shelf-life of the final 
product and to assess the injectability of the product through various needle gauges (23G, 
27G, and 30G). The mixing and filling time-frames were evaluated by determining the 
gel-point of the composite under small angle oscillatory shear. Process parameters, such 
as temperature, evaporation and the age of the initial silica sol were examined to optimize 
the filling process. The broadest time-fame was achieved by utilizing unaged silica sols 
in sealed process systems at refrigerator temperatures (4-8 °C). Respectively, the shelf-
life of the final product was also characterized by oscillatory measurements, which indi-
cated that the composite retained its viscoelastic characteristics for at least 30 days, re-
gardless of changing microparticle concentrations. Lastly, the final product was injected 
out of 1ml syringes through thin needles to evaluate the injectability of the product. Ulti-
mately, a microparticle concentration of 0.75 g/ml exhibited the most prominent injecta-
bility characteristics out of all the concentrations investigated. 
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Tutkielman toimeksiantaja oli DelSiTech Oy, joka on erikoistunut silikapohjaisiin lää-
keannostelutekniikoihin. Työn tavoitteena oli valmistaa injektoitava silikamikropartik-
keli–silikahydrogeelikomposiitti lääkeruiskuihin. Komposiitin tarkoitus on toimia lääk-
keiden parenteraalisena annostelijana: silikamikropartikkelien sisälle on kapseloitu lää-
keainetta ja partikkelit kuljetetaan hydrogeelissä haluttuun kohteeseen injektoitaessa. 
Mikropartikkelit oli valmistettu ennen työn aloittamista sumukuivaamalla silikasooleja, 
jotka oli tuotettu sooli-geeli-tekniikalla. Silikageelit valmistettiin tutkimuksen aikana 
sooli-geeli-tekniikalla. Silikageelien lähtöaineena käytettiin tetraetyyliortosilikaattia ja 
geelien R-arvo (veden suhde silikaattiin) vakioitiin arvoon 400.  
Homogeenisen komposiitin aikaansaamiseksi oli tärkeää sekoittaa mikropartikkelit sili-
kasooliin, joka muuttui geeliksi ajan edetessä. Soolin geeliytyminen kuitenkin nopeutui 
merkittävästi, kun siihen sekoitettiin silikamikropartikkeleita – toisin sanoen valmistettu 
komposiitti muuttui geeliksi nopeasti. Tämä aiheutti haasteita, sillä komposiitin tuli muut-
tua geeliksi vasta lääkeruiskujen sisällä. Näin ollen tutkimukselle asetettiin kolme tavoi-
tetta.  
Ensimmäinen tavoite oli optimoida komposiitin valmistusprosessi säätelemällä lämpöti-
laa, haihtumista ja sekoituksessa käytetyn soolin ikää. Prosessi optimoitiin reometrisilla 
oskillaatiomittauksilla, joiden avulla komposiittinäytteille määritettiin geelipiste. Geeli-
pisteen avulla rajattiin aikaikkuna, jonka aikana ruiskut tuli täyttää komposiitilla. Tutki-
muksessa havaittiin, että jos komposiitti valmistettiin tuoreesta silikasoolista, haihtumi-
nen minimoitiin ja prosessilämpötila oli + 4 °C, komposiitin geeliytyminen hidastui mer-
kittävästi. Näin ollen ruiskujen täyttöaika piteni. Toinen tavoite oli tutkia lopputuotteen 
(komposiitilla täytetty lääkeruisku) säilyvyyttä. Tätäkin tutkittiin oskillaatiomittauksilla, 
joilla kartoitettiin mahdollisia muutoksia komposiitin viskoelastisissa ominaisuuksissa 
varastoinnin aikana. Kuukauden kuluttua tuotteessa ei havaittu muutoksia. Kolmas ta-
voite oli tutkia komposiitin injektoitavuutta. Komposiittia injektoitiin erikokoisten neu-
lojen (23G, 27G ja 30G) läpi. Viskositeettimittauksilla määritettiin ja osoitettiin kompo-
siitin leikkausohenevuus. Lopuksi havaittiin, että mikropartikkelien pitoisuudella on 
suuri vaikutus komposiitin injektoitavuuteen. Lupaavimmat tulokset injektoitavuuden su-
hteen saavutettiin pitoisuudella 0,75 g/ml. 
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GLOSSARY 
 
23G    Needle gauge (0.6 x 30 mm) 
27G    Needle gauge (0.4 x 20 mm) 
30G     Needle gauge (0.3 x 13 mm) 
G´    Shear storage modulus 
G´´    Shear loss modulus 
Gel-point   When tan δ = 1 and begins to approach 0   
HCl    Hydrochloric acid 
Hydrogel   Water dispersed in a continuous solid phase  
NaOH    Sodium hydroxide 
R-value   Water to silica alkoxide molar ratio 
Silica    Silicon dioxide (SiO2) 
Sol    A colloidal suspension of small particles dispersed in liquid 
tan δ    loss tangent (tan δ = G´´/G´) 
TEOS    Tetraethoxysilane (Si(OC2H5)4) 
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1. INTRODUCTION 
The objective of controlled drug delivery is to provide effective drug administration to a 
specific location in a patient (e.g. a specific organ or organic system). Controlling the 
delivery is of great concern, since indiscriminate drug delivery can lead to severe or lethal 
side effects. This in turn decreases the therapeutic value of a drug. Furthermore, effective 
drug administration implies the ability to control the distribution of a drug, not only in 
space, but also in time. [1, p. 322-323.] In other words, the drug delivery system should 
elicit a controlled release rate of the therapeutic agent for a predetermined period of time 
in a specific location in the body of a patient. Essentially, the controlled release of a drug 
is designed to maintain the drug concentration in the body within the optimum therapeutic 
range. This range is determined by the minimum therapeutic threshold (lower limit) and 
the toxicity threshold of the drug (upper limit) [2, p. 19-22]. As a result, by maintaining 
the optimum therapeutic range of a drug and by targeting said drug, the overall therapeutic 
efficiency of the delivery system is increased. Regarding effective delivery systems, great 
examples include silicon dioxide -based systems.  
Silicon dioxide (SiO2), also referred to as silica, is an inorganic material widely used in 
different applications ranging from microelectronics to medical devices. Nevertheless, 
the scope of this study is on silica as a biodegradable biomaterial. More precisely, the 
study is focused on sol-gel processed spray-dried silica-gel microspheres applied in the 
field of controlled drug delivery. The mandator of the study was DelSiTech Ltd, which is 
a leading technology specialist in biodegradable silica-based controlled release systems. 
The ultimate goal was to manufacture a stable and homogenous silica-silica composite 
into syringes, in order to produce prefilled (“ready-to-use”) products. The composite 
consisted of silica-gel microparticles (as such) dispersed in a silica-hydrogel. The 
microparticles were manufactured prior to the study by spray-drying sol-gel derived silica 
sols. The silica hydrogels were also derived by a sol-gel method. Once the silica 
microparticle-silica hydrogel composites were prepared, their viscosity and viscoelastic 
properties were characterized with a rheometer. Rheological measurements are presented 
in Chapter 2.2, whereas the key features of sol-gel processing are described in Chapter 
2.3.  
The viscosity of a silica sol, which is essentially a suspension of silica nanoparticles and 
nanoparticle aggregates, rises as a function of time. This increase in viscosity is governed 
by the formation of an increasing number of silica nanoparticles within the sol. These 
particles and particle-chains are formed by a condensation process. Consequently, as more 
nanoparticles are formed they aggregate into large clusters and chains. In the end, a solid 
continuous three-dimensional structure is formed trapping in discrete liquid phases – the 
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sol has transformed into a gel. As a result, the silica microparticles had to be mixed with 
the silica sol before it had been allowed to form a gel. This ensured that the microparticles 
could be homogenously dispersed within the sol. Furthermore, after mixing the 
microparticles with the silica sol, the gelation rate of the mixture was seen to dramatically 
increase. This indicated that the microparticles may act as nucleating agents within the 
sol matrix hastening the gelation. [3.]   
The gelation rate of the composite had to be determined, in order to control the filling 
process of the syringes. This rate is dependent upon several variables, but the ones 
investigated here were the following: temperature, evaporation and the age of the silica 
sol used in the manufacturing process. The results are accordingly discussed in Chapter 
4. Additionally, the shelf-life of the composite was investigated by oscillatory 
measurements. During these shelf-life studies it was paramount to determine the first 
point-in-time when the composite had stabilized inside the syringe and could therefore 
withstand the injection process. This stabilization period also dictated how long the 
syringes were to be stored in a way to prevent particle sedimentation from occurring (i.e. 
kept in rotational motion). However, once the gelation process was complete and the 
microparticles were locked in place, the syringes could be stored in static conditions.  
Finally, the injectability profile of the composite was studied by injecting the composite 
through various needle gauges (23G, 27G and 30G). In this way, the suitable needle size 
to be used in administering the composite to a patient was determined. Generally, a 
thinner needle correlates with a less painful procedure for a patient. Moreover, a thinner 
needle allows for a wider range of locations to which the therapeutic agent can be 
parenterally administered. For these reasons, the concluding aim was to manufacture a 
composite which could be successfully injected through the thinnest (30G) needle used 
in this study.          
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2. THEORETICAL SECTION 
2.1 Rheology and rheometry 
Rheology describes the deformation of solids, liquids and gasses when they are subjected 
to external stresses. On the other hand, rheometry determines and quantifies the 
rheological properties of materials (i.e. rheometry refers to the experimental techniques 
of rheology) [4, p. 11][5, p. 112]. Respectively, the instruments used to measure 
rheological properties are known as rheometers. They can either apply deformation to the 
material investigated measuring the subsequent force produced, or they can apply a force 
mode to the material measuring the deformation generated [5, p. 112-113]. Thus, 
viscoelastic properties of materials (e.g. solids, semi-solids, fluids) can be determined 
with rheometers. Separated from this definition are instruments referred to as 
viscometers, which are limited in their use. These devices can only be used to measure 
the viscous flow behavior of fluids [4, p. 13].  Although basic rheological phenomena are 
discussed in the upcoming chapters, it is advisable that a reader unfamiliar with the basics 
of rheology would refer to these excellent publications [4][5][6]. 
2.1.1 Shear stress and shear rate 
In order to measure viscosity and understand the basics of rheology one must first define 
the parameters which are involved in the flow of solids, liquids and gasses. These 
parameters are shear stress and shear rate. Shear stress (τ) indicates a force (F) applied 
tangentially to an area. When sufficient shear stress is applied to a liquid, the liquid will 
begin to flow. The internal resistance (i.e. viscosity) of the liquid will dictate the velocity 
of the flow that can be maintained with a given force. [4, p. 15-16.] On the other hand, 
shear rate (ẏ) simply defines the rate at which the shearing force is applied. For example, 
in a parallel-plate rheometer design (see Chapter 2.2.1) τ causes the liquid between two 
parallel-plates to flow as the upper plate is rotated while the lower plate is stationary. The 
liquid then flows with a maximum flow speed at the upper plate. When approaching the 
stationary plate, the flow speed of the fluid gradually drops. Thus, the fluid flows with a 
minimum speed (vmin = 0) at the boundary of the bottom stationary plate. This drop in 
speed is used to calculate the applied shear rate during the measurement [4, p. 15-16]. 
Now we are able to define viscosity (η) as the ratio of shear stress and shear rate (η = τ/ 
ẏ). In general, viscosity expresses a fluids resistance to deformation under stress (e.g. 
shear stress). Furthermore when the viscosity of a liquid is constant for any values of ẏ it 
may be referred to as a Newtonian liquid. However in practice, this is rarely the case. A 
majority of liquids are Non-Newtonian liquids, meaning their viscosity is dependent on 
shear rate. [6, p. 62.] 
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Non-Newtonian behavior is commonly sub-categorized into different behavioral models. 
These classifications are not investigated in this study with the exception of pseudoplastic 
(i.e. shear-thinning) liquids. The term shear-thinning is used to describe non-Newtonian 
fluids which viscosity decreases as a function of shear rate. [4, p. 21-24.] The 
characteristic flow and viscosity curve charts for pseudoplastic liquids are shown in 
Figure 2.1. 
 
Figure 2.1. The shear rate dependence of pseudoplastic liquids. The flow curve plots 
shear stress as a function of shear rate. The viscosity curve on the other hand plots 
viscosity as function of shear rate. [4, p. 24.]   
In conclusion, shear stress causes a rate of strain in liquids but a strain in solids. Meaning 
that liquids flow and solids undergo elastic deformation. Nevertheless in reality all flow 
and deformation of real bodies (solids, liquids, and gasses) contain some elements of both 
flow and elasticity [7, p. 507]. This is the concept behind viscoelasticity which is up for 
discussion next. 
2.1.2 Viscoelasticity 
When describing the rheological behavior of a majority of actual materials the most 
relevant term to be used would be viscoelasticity. Even liquids considered as Newtonian 
liquids (e.g. water) present viscoelastic effects (elastic potential) under special 
measurement conditions, such as very high frequencies [6, p. 245]. This aspect is also 
true for Non-Newtonian fluids. For instance, the transformation of a sol-gel derived silica 
hydrogel from a “runny” suspension into a “thick” gel can only be observed at low 
frequencies (i.e. slow deformation) with minor deformation. On the other hand, even solid 
objects (e.g. glass windows) can appear to flow, but require years of observation.  
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In essence, viscoelasticity is a combination of properties characteristic for liquids 
(dissipative viscous loss) and solids (storage of elastic energy). Thus, the general 
definition of a viscoelastic material holds two main components: the potential to store 
elastic energy and the intensity to dissipate energy. [6, p. 245-248.] Correspondingly, 
these components are referred to as the Young’s storage modulus (E´) and the Young’s 
loss modulus (E´´), whereas their shear counter parts are known as the shear storage 
modulus (G´) and the shear loss modulus (G´´) [7, p. 362-363].   
Then the shear moduli values are used in calculating a variable referred to as the loss 
tangent (tan δ), which is the ratio of G´´ to G´ (tan δ = G´´/G´) [7, p. 363]. The loss tangent 
can be used to determine whether a material behaves more like a solid, G´> G´´ (tan δ < 
1), or more like a liquid, G´ < G´´ (tan δ > 1). Thus the loss tangent can also be used to 
evaluate a materials gel-point. [6 p. 257.] For instance, silica gels derived via sol-gel 
processing (see Chapter 2.3.3) elicit a gel-point. In order to better understand what this 
gel-point is exactly, the terms sol and gel should be defined first. 
The term sol referrers to a colloidal suspension of small particles dispersed in liquid. For 
example, a silica sol is homogenous mixture with at least one continuous liquid phase 
(water, ethanol, and residuals of silica precursors) and at least one dispersed solid phase 
(colloidal and/or aggregated silica particles) within the liquid phase. In contrast, a silica 
gel is a homogenous mixture of at least one continuous solid phase (silica as such and/or 
partially or fully hydrolyzed) and at least one dispersed liquid phase (water, ethanol and 
residuals of silica precursors) trapped within the solid phase. This means that a gel has 
dominant elastic properties over its liquid properties, whereas a sol has dominant liquid 
properties. Consequently, a gel-point is the point in time when a sol turns into a 
viscoelastic gel with dominant elastic properties. This point in time, if it exists, can be 
observed by rheological measurements under small angle oscillatory shear. [8, p. 4-5.]  
2.2 Rheometers and measurements 
Rheometers are instruments used to measure viscoelastic properties of solids, semi-solids 
and fluids. Furthermore, rheometers are important devices in the rheological 
characterization of non-Newtonian liquids and can be roughly classified into two different 
types: rotational and extensional rheometers. The difference being, that rotational 
rheometers either apply controlled shear stress or strain, and extensional rheometers either 
apply controlled extensional stress or strain. [4, p. 36-81][9, p. 75-106.] The Theoretical 
section of this study will focus on rotational rheometers owning a parallel-plate measuring 
geometry. Various measuring geometries (sensor systems) for rotational rheometers are 
defined and discussed in the next chapter. 
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2.2.1 Rotational rheometers 
Rotational rheometers are generally categorized in the following way: controlled stress 
(CS-rheometers) and controlled rate (CR-rheometers) rheometers. However some 
modern rheometers are able to operate in both test modes. Basically, CS-rheometers input 
a controlled shear stress and determine the resulting shear rate, whereas CR-rheometers 
do the exact opposite. The similarity between these two types of rheometers is that both 
devices are usually supplied with the same array of sensor systems: the coaxial cylinder, 
cone-and-plate and parallel-plate systems. In addition to the two rheometer categories 
(CS- and CR-rheometers) there are two subcategories for these rotational rheometers: 
Searle- and Couette-measuring system. [4, p. 36.] These systems are illustrated and their 
differences explained in Figure 2.2.    
 
Figure 2.2 Different types of rotational rheometers. The letter “M”, in Figure 2.2, stands 
for a motor which rotates and drives the systems and for which specific torque values can 
be set. The spring (B1) acts as a torque detector between the drive motor and shaft. 
Picture edited from source. [4, p. 37.] 
In general rotational rheometers measure the torque needed to rotate an object in a liquid 
(e.g. cylinder) or on the liquid surface (e.g. plate), at a certain speed. In a Searle system 
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the shear rate (case A) or the torque (case B1) is measured on the rotor axis with the drive 
motor “M”. In contrast, in a Couette system the outer drive motor “M1” rotates at a 
predefined speed, which causes the liquid in the annular gap to flow. This in turn generates 
torque on the inner object (e.g. cylinder, cone, plate). Consequently, the generated torque 
would prompt the inner object to also rotate, but instead a counteracting torque is supplied 
by a secondary motor “M2” – keeping the inner object from rotating. Thus, the Couette 
system measures the counteracting torque required to keep the inner object still.  Meaning 
that the drive motor operates at the outer object (i.e. cup) while the viscosity related torque 
is measured on the shaft of the inner object (i.e. bob). In conclusion, a Searle system 
design has the drive motor and the torque detector on the same rotor axis, but a Couette 
system has these two elements separately. This is the distinctive difference between the 
Searle and Couette system designs. [4, p. 37-40.]      
2.2.2 Viscosity measurements 
Instead of leading CR or CS mode experiments with a rotational rheometer, one can have 
the choice of ramping or stepwise controlling the changing parameter (shear stress or 
rate). For example, in a CS/CR ramping -procedure either a preset shear stress or shear 
rate is gradually increased or decreased and the resulting shear stress/shear rate is 
measured. Thus, there are four different methods to form a flow or viscosity curve (see 
Figure 2.1) for a sample. [10, p. 54-60.] From the plotted curves, the samples Newtonian 
or non-Newtonian flow characteristics can be determined.  
2.2.3 Oscillatory measurements 
Oscillation testing is intended to be a non-destructive test method. By utilizing this type 
of testing, one is able to separate the elastic and viscous properties of a material (e.g. 
gels). During oscillation testing a sample material is exposed to a sinusoidal stress defined 
by an amplitude of stress (τ0) and frequency of the applied deformation (ω). In other 
words, when executing an oscillatory test with a rotational rheometer the rotor no longer 
turns continuously in one direction as it did with viscosity measurements. This time the 
rotor is made to pivot with a small angle (ϕ) to the left and to the right. Subsequently, 
when a shear stress (τ) is applied to a sample it will undergo deformation (γ). Depending 
on the relation of viscous and elastic properties of the sample a phase shift δ may present 
between τ and γ. This means that the amplitude of deformation (γ0) is not necessarily 
reached at the same time as τ0. However, for pure elastic materials the phase shift is 0° 
and purely viscous materials present a phase shift of 90°. Accordingly, viscoelastic 
materials elicit a phase shift between 0° and 90°. [10, p. 80.] As a side note, in literature 
handling rheology, it is most common to model viscoelastic behavior as linear 
combinations of springs (elastic element) and dashpots (viscous element) in order to 
forecast the response of a material under various loading conditions. These spring and 
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dashpot models, which include the Maxwell and Kelvin-Voight model, are ruled out of 
inspection. 
When conducting oscillation tests there are several types of different oscillation 
procedures (i.e. tests) one can choose to characterize their sample materials. Nevertheless, 
a popular and relevant method to study the viscoelastic behavior of gels is to conduct 
frequency sweep –procedure. During this procedure, the sample is exposed to an array of 
different frequencies under a controlled stress or deformation value. The sample must 
remain unchanged throughout this test procedure. Therefore, the applied stress or 
deformation value must remain in the sample materials linear viscoelastic range. This 
range can be determined by an oscillation stress sweep –test (i.e. amplitude sweep –
procedure) in which the sample is subjected to gradually rising stress amplitudes. As the 
stress amplitude is increased, the sample will eventually yield. After this yield point, the 
sample no longer functions in the linear viscoelastic range in which the stress and strain 
amplitude have a linear relationship. Practically speaking the linear viscoelastic range is 
a region where material functions are independent of stress or strain values. [10, p. 80-
94.]   
2.3 Biomedical biomaterials 
Defining the word “biomaterial” has proven to be somewhat problematic throughout 
history, since the field of biomaterials science has been constantly progressing and 
biomaterial applications have become more complex. Therefore, the definitions may vary 
to a certain degree, according to different sources.  
The European Society for Biomaterials (ESB) defines biomaterials in the following way: 
“material intended to interface with biological systems to evaluate, treat, augment, or 
replace any tissue, organ or function of the body.” [11.] On the other hand, the 
International Union of Pure and Applied Chemistry (IUPAC) defines a biomaterial as: 
“material exploited in contact of living tissues, organisms or micro-organisms.” [12.] This 
word definition has been a subject of debate between the biomedical and environmental 
fields, because certain extensions to the definition (e.g. material of natural origin) cannot 
be extended to non-viable materials used in medical devices [12]. Nevertheless, 
biomaterials can be metals, ceramics, polymers and composites, and can additionally be 
classified into four groups: inert, natural, bioactive and biodegradable [13, p. 84]. Out of 
these four groups, only biodegradable biomaterials are discussed in detail. More 
specifically, sol-gel derived biodegradable polymeric silica gels. Before discussing 
polymeric silica, a short introduction into degradation is given first. Understanding 
various degradation mechanisms is of crucial importance when developing degradable 
biomedical applications, because the degradation process can govern a range of different 
events such as drug release, host response, material function and tissue regeneration [15, 
p. 179]. 
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2.3.1 Biodegradation and bioerosion 
The term biodegradation is often used to signify degradation occurring in a biological 
environment driven by a specific biological reaction/process [14, p. 179]. Degradation on 
the other hand refers to a chemical process occurring in polymeric materials, resulting in 
the cleavage of covalent bonds. Therefore, changing the materials initial chemical 
structure. In contrast, the gradual breakdown of bioceramics is often discussed and 
characterized by terms, such as: absorption and resorption. Absorption indicates how 
materials are gradually drawn into a system, whereas resorption characterizes how a 
material is gradually broken down into smaller components which are then assimilated 
into the governing system [11]. Evidently, when these phenomena occur in biological 
conditions the terms absorption and resorption may be referred to as bioabsorption and 
bioresorption. In general, resorption and bioresorption are used to emphasize that the 
components taken in by a system are taken in again. For example, as bone tissue 
undergoes resorption the bone is broken down to its mineral components, which are then 
assimilated by the tissue to form new bone (continuous circulation).  
Consequently, the gradual breakdown of materials lead to physical property changes in 
them, such as mass loss and shape distortion. These physical changes in size, shape and/or 
mass are referred to as erosion, which can occur via degradation, dissolution, absorption, 
resorption, ablation and/or mechanical wear. Thus, as with erosion, the occurrence of 
bioerosion can also be governed by physical and/or chemical processes. However, the 
distinctive difference between erosion and bioerosion is that bioerosion occurs under 
biological conditions as opposed to being triggered by abiotic factors (e.g. heat, radiation, 
mechanical stress). [15, p. 179.]  
Both erosion and bioerosion can be categorized into two separate modes: surface and bulk 
erosion. Surface erosion is limited to the surface of a device exposed to a reaction 
medium. Meaning, that the erosion process begins at the exposed surface and proceeds 
into the inner core of the device layer by layer. In contrast, during bulk erosion the whole 
device erodes homogenously throughout the entire matrix, because the reaction medium 
is able to penetrate into the bulk of the device. [16, p. 88-89.] Typically in bulk erosion 
the device will crumble into smaller pieces as cracks and crevices are formed throughout 
the device. This in turn, lets in exceeding amounts of reaction medium into the device 
leading to an increasing decomposition rate.  This aspect is illustrated in Figure 2.3, which 
also depicts how the surface erosion pattern proceeds. 
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Figure 2.3. The differences between bulk and surface erosion at arbitrary time periods. 
During the surface erosion process the material erodes layer by layer, whereas in bulk 
erosion the material erodes homogeneously as a reaction medium is taken in by the 
material, eventually crumbling it. Edited from source. [16, p. 89.] 
When making a distinction between degradation, biodegradation, absorption, 
bioabsorption, erosion and bioerosion it is adamant to understand that the prefix “bio” is 
not well established and can lead to some confusion in terms of terminology [15, p. 180]. 
Thus, biodegradation and bioabsorption may be used to simply emphasize that the 
structure of a material degrades in a biological entity or system. Disregarding whether or 
not the degradation process is meditated by biological, chemical and/or physical factors. 
Consequently, bioerosion can be understood as a process meditated by dissolution, 
degradation, ablation and/or mechanical wear in physiological and biological conditions. 
Bioerosion will eventually result in physical property changes of a device and in the loss 
of its function. [17]. Defining biodegradation and bioerosion in this manner (only a 
biological surrounding is needed) is crucial when speaking about silica, because silica 
degrades via chemical rather than biological processes in a biological environment. For 
example, when silica is introduced into the human body it will dissolve into the water 
phase of the extra cellular matrix (ECM) and is ultimately excreted out as silicic acid. 
Regarding silica microparticles, their bioerosion and biodegradation is discussed further 
in the Drug delivery technology chapter, because these mechanisms control the rate of 
drug released from within the microparticles.  
2.3.2 Sol-gel processing of silica gels 
Silica gels can be classified as polymer-silica nanocomposites (i.e. polymeric silica) 
which belong to a class of materials referred to as organic/inorganic nanocomposites. 
Unlike conventional composites, which have macroscale domain sizes, polymeric silica 
nanocomposites are generally nanoscopic. [18, p. 1.] Although, different methods of 
producing these polymeric silica nanocomposites exist, only the sol-gel approach is 
discussed here.     
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Sol-gel derived silica gels are prepared from monomeric tetrafunctional alkoxide 
precursors. The most common precursors used in silica gel synthesis are tetraethoxysilane 
(Si(OC2H5)4) abbreviated as TEOS and tetramethoxysilane (Si(OCH3)4) abbreviated as 
TMOS. These monomeric precursors in an aqueous solution are commonly hydrolyzed 
by employing a mineral acid (e.g. HCl) or a base (e.g. NaOH) as a catalyst. Since water 
and alkoxysilanes are immiscible, a reciprocal solvent (e.g. ethanol) is often used to 
homogenize the mixture. [19, p. 108-112.] However, solvents or homogenizing agents are 
not necessarily required when preparing certain materials. For example, when preparing 
silica gels from TEOS, a solvent-free method can be utilized. This is possible due to the 
fact that alcohol is produced, as a by-product, when TEOS is hydrolyzed. The produced 
alcohol in itself is sufficient enough to homogenize the initially biphasic system allowing 
the system to polymerize [20].   
The polymerization process of aqueous silica is driven by hydrolysis, which replaces 
alkoxide groups with hydroxyl groups (OH), and condensation reactions, which produce 
siloxane bonds (Si-O-Si). Congruently, the by-products of these reactions are alcohol and 
water. The hydrolysis and condensation reactions are subsequent processes, but under 
most conditions condensation begins before the hydrolysis is complete. [19, p. 108-112.] 
The polymerization process can be described to progress in three stages. The first stage 
being the polymerization of the monomer to form particles, which then grow in size. In 
the end, as the particle grow and aggregate, they link into chains which extend throughout 
the liquid medium (i.e. thickening it to a gel) [21]. Furthermore the growth and 
aggregation behavior of the particles are greatly affected by pH and/or by the presence of 
flocculating salts. This dependence is illustrated in Figure 2.4. 
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Figure 2.4. In acidic solutions or in the presence of salts (A) particles aggregate to three-
dimensional networks and form gels. In basic solutions (B) particles grow in size 
simultaneously decreasing in number [21, p. 174]. Considering this study, the sol-gel 
reactions were led via route A. Choosing route B over A would have most likely resulted 
in an unstable final product or the desired three-dimensional gel structure might have not 
formed in the first place.             
The pH-dependence of the polymerization process is of great significance in the 
successful manufacturing of silica gels. According to Ilier [21, p. 213-222], the 
polymerization process can be divided into three pH domains: the first domain being < 
pH 4, the second domain pH 4-7 and the final domain > pH 7. The first domain is 
characterized by the point of zero charge (PZC), where the surface energy is zero, and the 
isoelectric point (IEP), where the electrical mobility of the silica particles is zero. Both of 
these points are found in the range of pH 1-3. Therefore pH 4 performs as a boundary 
point. The other boundary point is at pH 7. Above this pH silica particles are ionized, 
which mainly leads to particle growth without sufficient aggregation or gelation from 
occurring within the sol. [19, p. 103][22, p. 775.] These domains are depicted in Figure 
2.5, in which sol stability is plotted as a function of pH. 
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Figure 2.5. The pH-dependence of colloidal silica-water systems. Three different pH 
domains can be distinguished: metastable, rapid aggregation and particle growth without 
aggregation or gelation [22, p. 775]. 
The metastable domain around pH 2, illustrated in Figure 2.5, clearly depicts a peak value 
in sol stability and an increase in gelation time. In this domain hydrolysis reactions are 
dominant over condensation reactions. This is due to the fact that under acidic conditions 
an alkoxide group is protonated decreasing the electron density of silicon. This results in 
a more electrophilic silicon, which in turn makes it more susceptible to hydrolysis. In 
addition to hydrolyzing monomers, the reaction produces alcohol as a by-product, which 
serves as a homogenizing agent. [19, p. 131.]  
Acid-catalyzed hydrolysis is reported to be more effective compared to a base-catalyzed 
technique. Moreover an increased R value, which indicates the mole amount of water to 
TEOS, has been shown to promote hydrolysis resulting in a more complete hydrolysis of 
monomers. Although high values of R cause immiscibility in the biphasic mixture, 
alcohol produced by the hydrolysis reaction and the partial hydrolysis of the TEOS 
precursor lead to homogenization. [19, p. 127.] An R value of 400 is considered to be an 
extremely high value, since sols at this point are at the brink of not being able to form a 
cross-linked system through-out the aqueous medium (i.e. unable to form a gel). One 
reason behind this inability is that, besides promoting hydrolysis, high values of R also 
promote siloxane bond hydrolysis. This reaction is the reverse reaction of the polymer 
condensation and is promoted by large R values [19, p. 127]. 
Condensation reactions on the other hand are promoted and accelerated near neutral pH 
(see Figure 2.5). The gel time (tgel) of sol-gel systems is often used to measure overall all 
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condensation kinetics, so that the average condensation rate is expressed as inversely 
proportional to the gel time (average condensation rate ≈ 1 / tgel) [19, p. 140]. 
Consequently, the minimum condensation rate can be observed near the isoelectric point 
and maximum rate near pH 6 (see Figure 2.5). It is evident that by manipulating the pH 
of silica sols one can control the rate of hydrolysis and condensation reactions occurring 
in the system by accelerating or de-accelerating the other. 
2.3.3 Applications of silica gels 
The use of sol-gel derived silica materials have already been incorporated in various 
commercial applications in many different fields of technology and research such as 
construction, tissue engineering, drug delivery and coating technologies. This widespread 
attention in many areas is a result of the fact that porous silica matrices are easily tailored 
into several different morphologies. Ranging from spherical nano- and microparticles to 
monolithic devices with various shapes and sizes. Additionally sol-gel derived silica owns 
a unique set of physio-chemical properties which have led it be incorporated in the 
manufacturing of construction materials.  
Silica nano- and microparticles have been used to mechanically reinforce cement and to 
enhance thermal, abrasion and surface hardness properties of composite coatings. [23, p. 
31-34.] In contrast different biomedical fields such as controlled drug delivery and tissue 
engineering has benefited from the fact that amorphous sol-gel processed silica is both 
compatible and degradable in living tissue [17, p. 382]. For example, silica nano- and 
microparticles have been incorporated into commercial bioactive glasses in order promote 
their bioactivity. Silica has enhanced the adhesion properties of these biomedical ceramic 
implants and stimulated cell proliferation as well as migration of cells into the implant. 
This has helped in preventing marginal gap formation at the implant-tissue interface 
[24][25]. Nevertheless, the most interesting field, regarding this study, is the field of 
controlled drug delivery. Specifically, the application of sol-gel derived amorphous silica 
microparticles, which provide the possibility to encapsulate different biologically active 
agents [17][26]. 
2.4 Drug delivery technology 
The main objective of the interdisciplinary field of drug delivery is the accurate 
administration of bioactive agents, commonly referred to as drugs, to achieve a sought 
after clinical response. Achieving this objective is known to be somewhat problematic, 
but recent advances have led to the development of sophisticated drug delivery 
technologies, such as controlled release, sustained release and targeted delivery systems.   
Modern drug delivery technologies can offer the advantages of reducing drug dose 
frequencies, provide a more constant drug effect over time, reduce drug side effects, 
maintain therapeutically effective drug concentrations in plasma and offer the capability 
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of being selectively active in specific areas in the body (e.g. cancer tissue). [27][28.] The 
terms targeted, controlled release and sustained release systems are defined as follows. 
Sustained release systems prolong the duration of drug effects by slowing down the 
release of the drug. On the contrary, a controlled release dosage form does not merely 
delay the release rate, but delivers the drug at a specific rate for a preset time. Moreover, 
targeted delivery systems are often understood to be a part of controlled release systems, 
because they often provide a site-specific drug delivery. In addition to attaining temporal 
control. [27.] This focus of this study is on controlled release systems, more precisely on 
the dissolution controlled systems (see Chapter 2.4.2). Furthermore, the use of spray-
dried silica microparticles in drug delivery is discussed. Ruling other drug delivery 
systems out of inspection. 
2.4.1 Routes of drug administration 
Every drug molecule, upon administration, warrants a delivery system to carry the drug 
to the site of action in a patient. Therefore, various routes of drug administration and 
dosage form types exist. Conventional dosage forms, up until the 1970s, essentially 
comprised of injectable solutions, oral formulations and topical creams and ointments. 
Since then many other dosage forms have been invented for many different routes of 
administration [29, p. 1-3]. These routes can be categorized into invasive and non-
invasive routes. The distinctive difference being that non-invasive routes utilize the 
natural orifices of a patient (e.g. rectum). However, invasive methods rely on entering the 
body by punctures or incisions. Thus, non-invasive methods include oral, topical (e.g. 
skin), transmucosal (nasal, buccal, vaginal, ocular and rectal) and inhalation routes, while 
invasive methods include parenteral routes, such as subcutaneous, intravenous, 
intramuscular and intraocular [27]. 
When designing a parenteral route for a delivery system, many different parameters must 
be taken into account. Nonetheless, one major factor exists: needle gauge from which the 
product can be injected through. The size of the needle often determines the final site in 
which the product can be appropriately injected to. For example intraocular 
administration methods tend to require very small needle sizes (e.g. 30G), whereas 
subcutaneous injections are commonly performed with larger needles (e.g. 23-26G). 
Although fine needles reduce the pain of injection thus increasing patient comfort, they 
also require an increased force upon the injection of the drug. [30][31.] While patient 
convenience and compliance plays a vital role in developing a successful drug delivery 
technology, maximum patient comfort cannot always be achieved, since pain is a 
subjective experience and certain drug characteristics (e.g. large molecule size) prevent 
the use of fine needles, such as 27G-30G.             
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2.4.2 Controlled drug release systems and kinetics 
In principal, controlled drug release systems deliver a preset drug dose, either 
systematically or locally, at a predetermined rate for a predetermined time period [32, p. 
56]. Drug release can be understood as the process in which a drug molecule migrates 
from its initial position inside the drug delivery device to the outer surface of said device 
and then to the release medium (e.g. blood). This unseeingly difficult process is affected 
by a multitude of different intricate factors and their reciprocal interactions. These factors 
include, but are not limited to, device geometry, the release environment and solubility of 
the drug compound. [33, p. 2.] Despite of this complexity, the mechanism by which drug 
release is controlled can be categorized into five different groups: diffusion-, dissolution-
, osmosis-, mechanical-, and bioresponsive controlled release mechanisms [32]. As with 
any classification method, grouping the different controlled drug release mechanism can 
be quite arbitrary. In this case even more so, since other release mechanisms can be 
considered to be the subsequent result of another mechanism. For example, swelling is 
sometimes classified as its own main category, but it can occur as the succeeding result 
of another reaction (e.g. a bioresponsive ligand-substrate interaction) [32, p. 60]. Also, 
swelling is mainly characteristic to just polymer-based drug delivery devices [33, p. 2]. 
Thus, Table 2.1 is merely one representation of how controlled drug release mechanisms 
can be classified.  
The focus of this chapter is on the dissolution release mechanism and other mechanisms 
are ruled out of inspection. The reason being, that the whole study focuses on amorphous 
silica microparticles, which are dissolution-controlled matrix devices in which minimal 
drug diffusion occurs [26]. Provided that the active agent is successfully encapsulated 
upon manufacturing the particles. 
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Table 2.1. The table represents one possible way of categorizing different controlled 
release rate drug delivery systems. Edited from source. [32.]     
 
Dissolution-controlled devices can be divided in into two groups: reservoir and matrix 
devices. Reservoir devices retain the drug behind a membrane, whereas in matrix devices 
the drug is dispersed within a continuous matrix. Their common denominator is that both 
devices (i.e. dissolution-controlled devices) must be water soluble and/or degradable in 
water. [32, p. 58.] The structural differences of these two devices are schematically 
illustrated in Figure 2.6. 
 
Release mechanism Subcategory 
1) Diffusion-controlled a) Reservoir devices 
 b) Matrix devices 
2) Dissolution-controlled a) Reservoir  devices 
 b) Matrix devices 
3) Mechanical-controlled a) Zero-order controlled drug release 
 b) Intermittent drug release 
4) Bioresponsive-controlled a) Biodegradation 
 b) Biotransformation 
5) Osmosis-controlled  
18 
 
 
 
Figure 2.6. Schematic illustration of a diffusion-controlled reservoir (left-hand side) and 
a diffusion-controlled matrix (right-hand side) systems. Edited from source. [32, p. 57.] 
The membrane, commonly a polymer, of a reservoir device is designed to dissolve after 
a certain time period thereby releasing the drug. The drug can also be released through 
the membrane by the drug first dissolving into it. However, in a matrix device the drug is 
released solely by the gradual dissolution or degradation of the device matrix. For a 
reservoir device the drug release can be controlled by modifying the thickness and/or 
dissolution rate of the membrane surrounding the drug core. More intricate reservoir 
devices incorporate different membrane materials and/or varying coating thicknesses in 
order to hasten and/or delay the drug release rate at certain time periods. Similarly, for 
matrix devices the release rate can be adjusted by the dissolution rate of the matrix. 
Another way to adjust the release rate is to design a non-linear drug concentration profile 
in the matrix, which is necessary for monolithic devices where the drug released decreases 
as the matrix decreases in size. [32, p. 59.] 
Often, the drug release mechanisms overlap one another. Meaning that at a given time 
more than one mechanism may be involved in delivering the drug and different 
mechanism may be dominant during the different stages of the drug delivery process [2, 
p. 19]. An array of different tests can be conducted in order to determine which 
mechanisms overlap or are dominant, but one underlining factor must be determined and 
characterized: a drug release profile. This profile is commonly presented either as the 
released drug concentration in plasma or the cumulative release-% of a drug as a function 
of time [28]. Generally, these release profiles are modeled by various mathematical 
models (e.g. Fick’s law, zero-order and first-order release,) with the purpose of 
simplifying complex release mechanisms and to comprehend the release process of a 
specific system. Therefore, a mathematical model concentrates on one or two dominant 
driving forces and are often inadequate to describe intricate multicomponent material 
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systems (e.g. stimuli-responsive systems). [33, p. 2.] Figure 2.7 depicts two different 
release profiles (zero-order and immediate) and illustrates how a therapeutically effective 
controlled release system would ideally deliver a drug compared to an immediate release 
drug delivery device (e.g. conventional orally administered drug capsules). 
 
Figure 2.7. Two different drug release profiles represented as drug concentration in 
plasma and plotted as a function of time. The two profiles are defined as: zero-order 
release (dot-dash curve) and immediate release (solid curve followed by a dotted curve). 
MTC stands for minimum toxic concentration and MEC for minimum effective 
concentration. The ideal therapeutic effect is achieved below the MTC and above the 
MEC, referred to as the therapeutic window. Multiple doses (dotted arrows) at regular 
intervals are required with immediate release drugs, resulting in a rapid rise and fall in 
drug concentrations whereas a zero-order release system will lead to constant 
concentration in plasma, after an initial rise, with a single dose (solid arrow). Edited 
from source. [2, p. 21.] 
In most cases, when designing a controlled release device, a zero-order release profile is 
desired. The reason being, that drug concentration fluctuations in bodily fluids can be 
minimized (see Figure 2.7). In other words, with zero-order release systems the delivery 
rate does not vary with time. Ideally the drug is released at a constant rate, subsequently 
maintaining an effective drug concentration in the body for a prolonged period of time. 
[29, p. 29-30.] This type of release is advantageous in treating many disease types, which 
makes it a desirable and sought after design. 
2.4.3 Silica microparticles and controlled drug delivery 
Extensive advances have been made in the past decades to enable more effective 
administration of drugs. Therefore a range different organic and inorganic drug delivery 
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systems have surfaced, some of which are illustrated in Figure 2.8. Still, the focus of this 
chapter is on silica particles. 
Figure 2.8. Different types of drug delivery systems and a short description of some their 
chemical properties. Edited from source. [34, p. 3.] 
Organic systems such as micelles, liposomes and polymeric nanoparticles tend to be 
limited in their use due to owning poor thermal and/or chemical stability. In addition, 
these materials are often rapidly eliminated by the immune system. Although, every 
system has its own advantages and disadvantages, silica particles can offer a 
biocompatible and stable alternative to organic controlled drug delivery -systems. 
Combining a sol-gel polymerization method (see Chapter 2.3.2) with either spray-drying 
or emulsion chemistry, biologically active agents can be encapsulated within silica 
particles with ease. [35-39.] Moreover, the sol-gel polymerization method provides the 
possibility of encapsulating a large variety of different biologicals into silica, such as 
small molecules, proteins, viruses and even entire cells [17, p. 382]. This is possible, 
because the sol-gel method is an ambient-temperature polymerization technique –
essential when handling biologically active agents [35, p. 1959-1960].  
After the sol-gel processing, spray-drying is a favorable method to produce spherical 
silica microparticles. Spray-drying also allows the processing of heat sensitive biologicals 
and offers the possibility to straightforwardly adjust various particle properties such as: 
size, porosity and size distribution. Although spray-drying faces certain challenges, such 
as low yield and surface segregation, it offers the advantage of being a single-step process. 
The process can even be readily scaled up and together with the sol-gel method it is an 
economically beneficial processing method. [26][35][40][41.]  
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Silica particles have also attracted ample attention as a novel drug-delivery system, 
because of their certain intrinsic properties: inherent hydrophilicity, non-toxicity 
(excluding crystalline silica), biodegradability and biocompatibility in living organisms 
[17, p. 382][35, p. 1960]. 
Amorphous silica microparticles intended for drug administration, undergo bulk erosion 
(defined in Chapter 2.3.1) meditated by the dissolution and biodegradation of silica under 
physiological conditions. Studies have shown that spray-dried silica microparticles are 
dense enough to prohibit any significant diffusion from occurring even with considerably 
small molecules (e.g. propranolol). However, trace amounts of drug diffusion is almost 
always witnessed in the form of an initial drug burst. For example, the drug burst (see 
Figure 2.9) witnessed with the majority of spray-dried silica microparticles can be 
explained by the presence of non-encapsulated and partially encapsulated drug molecules. 
These non-encapsulated drug molecules tend to rapidly dissolve in to the reaction 
medium. On the other hand, the partially encapsulated molecules tend to swiftly diffuse 
from the microparticle surface or from the vicinity of said surface. [17][26, p. 223.]  In 
an ideal scenario, every drug molecule is encapsulated in a way that this initial burst effect 
would be non-existent (i.e. every drug molecule is encapsulated into the vicinity of the 
inner core of a microparticle). 
 
Figure 2.9. The effect of an initial drug burst (t ≤ t1) on the release kinetics of zero-order 
drug delivery systems. After the burst effect (t ≥ t1), the drug release rate changes into a 
constant release mode. 
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Disregarding the initial drug burst effect, the drug release from within the microparticles 
is controlled by the biodegradation and dissolution of silica. Meaning that by modulating 
these two factors one can dictate, to some extent, the release profile of the silica-based 
drug delivery system. Studies have shown that the dissolution of silica can be adjusted 
relatively effortlessly with the following parameters: water-to-alkoxide ratio, amount of 
solvent, catalyst concentrations and various process parameters (e.g. aging and drying). 
In contrast, the degradation process and kinetics of silica microparticles are governed by 
parameters, such as porosity, chemical structure and the type of the drug molecule. 
[42][43.] 
Despite the fact that the dissolution and biodegradation of the microparticles result in bulk 
erosion, a zero-order release profile is observed for porous silica microparticle systems 
[44]. This is interesting, because typically a surface eroding drug delivery system exhibits 
zero-order kinetics, whereas a bulk eroding systems tend to show a variable release rate. 
Both of these release profiles are graphically represented as a function of time in Figure 
2.10. 
 
Figure 2.10. Typical release rates corresponding with surface (solid line) and bulk 
erosion (dash line). For bulk erosion the release rate depends on the total amount of 
material and as the material is depleted the release rate decreases. The resulting profile 
is known as variable release rate. In contrast, for surface eroding materials the release 
rate is directly proportional to the systems outer surface area. 
The reason why silica-based porous microparticle systems display zero-order kinetics, 
despite the fact that they undergo bulk erosion, is because the solubility of silica in 
aqueous solutions is substantially low. For this reason, in some scientific communities 
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there remains a misconception that silica is insoluble in aqueous conditions. [45, p. 12.] 
Consequently, as the porous silica microparticle is penetrated by an aqueous solution, the 
solution inside the microscopic pores quickly reach saturated silica levels. As a result, the 
dissolution rate of silica inside the concise pores is slow. Successively retarding the drug 
release. In a best case scenario, this results in a zero-order drug release profile, which is 
a desired and highly sought-after characteristic for many drug delivery systems. [44.]    
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3. EXPERIMENTAL SECTION 
3.1 Materials 
The materials used in this study were a standard array of different laboratory equipment 
(e.g. flasks and beakers), various reagents used in the sol-gel process and spray dried 
silica gel microparticles used as a carrier for pharmaceutical agents. Regarding this study, 
no drug molecules were encapsulated within the microparticles. In other words, all of the 
microparticles used were placebos. Furthermore, the microparticles had been 
manufactured before the study began. The silica gels were however synthesized during 
the study. All of the silica gels prepared can be referred to as hydrogels, since the 
dispersion medium was methodically water [46, p. 696].   
3.1.1 Sol-gel derived silica gels 
The prepared silica sols consisted of a 98% reagent grade tetraethoxysilane (TEOS), 
deionized water, 0.1 M hydrochloric acid (HCl) and 0.1 M sodium hydroxide (NaOH). 
The TEOS was supplied by Sigma-Aldrich® (USA). The deionized water was produced 
with a MILLI-Q Academic (USA) water purification system. Both the HCl and NaOH 
were supplied by Merck Millipore (USA) (reagents were Titripur® grade). The sol-gel 
process and the molar ratios of these reagents are discussed further on in the Methods 
chapter. 
3.1.2 Silica microparticles 
All of the microparticles were manufactured by a Contract Manufacturing Organization 
in Europe. The microparticle size distribution (PSD) for the batch (14SIT078 BR1A) of 
microparticles used were: X10 = 2.70 µm, X50 = 9.98 µm and X90 = 18.68 µm. The PSD 
was measured by laser diffractometry by using the Sympatec/Helos laser diffraction 
apparatus (Sympatec GmbH, Germany).  
In this study the process parameters applied in the spray-drying process and the process 
itself will not be discussed in great detail. For a more thorough investigation of the process 
it is suggested that the reader would review these excellent publications [26][47][48][49]. 
3.1.3 Syringes and needles 
The silica-silica composite was filled into two different types of syringes and injected 
through three different needle gauges. A clear majority of composites were prepared at 
DelSiTech (Finland) and were filled into 1 ml plastic luer syringes supplied by BD (USA). 
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A smaller portion of composites investigated in this study were manufactured by a 
Contract Manufacturing Organization (CMO) in Europe. The CMO filled the composites, 
they had manufactured, into 1 ml glass Gx RTF® luer-lock syringes supplied by 
Gerresheimer (Germany). Both of the syringe models could be fitted with separately 
supplied needles. 
The syringes were ultimately fitted with three different needles gauges to study the effect 
of needle size on the injectability of the composite. The needle gauges used were the 
following: 23G (0.6 x 30 mm), 27G (0.4 x 20 mm) and 30G (0.3 x 13 mm). The first 
numeral inside the brackets signify the outside diameter of the needle and the latter 
denotes the length of the needle. The 23G and 27G needles (Neolus™) were 
manufactured by Terumo (Japan), whereas the 30G needles (Microlance™) were 
manufactured by BD (USA)   
3.2 Methods 
The preparation of the composite basically consisted of two different stages. First the 
silica sol was prepared by a sol-gel method. Then the silica sol was pipetted into a plastic 
container holding previously weighed silica microparticles. Then the mixture was stirred 
for 10 minutes and filled into plastic syringes. The whole process however is described 
in greater detail in the upcoming chapters.    
3.2.1 Sol-gel method 
The formulation of the silica sol was kept constant during the whole study. The sol was 
prepared by first measuring TEOS, deionized water and HCl (0.1 M) at a mole ratio of 
1:400:0.01. In order to ensure a homogenous product, 200 ml of the sol was prepared each 
time. It is noteworthy that in calculating the amount of water needed, one must take into 
account the amount of water that exists in HCl (0.1 M). 
After measuring the reagents, the solution was vigorously stirred (1100 rpm) in a sealed 
laboratory bottle with a magnet stirrer for 25 minutes at room temperature.  This was done 
in order to achieve two things: firstly to speed up the hydrolysis process and to ensure 
that the initial solution had time to be entirely hydrolyzed into a sol. After the stirring, the 
pH of the sol (initially pH < 2) was raised to pH 6.2 (±0.1) with 0.1 M NaOH. This raise 
allowed for the condensation reactions to accelerate, lowering the gel-time of the sol 
accordingly. The purpose of this routine is explained in Chapter 2.3.3.             
3.2.2 Composite preparation and prepared samples  
Once the pH of the silica sol was set to a value of 6.2, the sol was considered to begin 
aging. Thus, each reported aging time was calculated from this point onwards. The 
composite was manufactured by mixing together spray-dried silica microparticles and a 
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silica sol, before the sol had thickened into a gel. Some experiments were however 
conducted in which microparticles were mixed into a silica gel. This method resulted in 
a heterogeneous final product owning poor injectability characteristics and the results 
were ruled out of this study. 
The microparticles were weighed into a 50 ml lidded plastic container. After the 
microparticle weighing, the silica sol (~ pH 6.2) was pipetted into the plastic container 
holding the microparticles. Utilizing a large pipette tip (5 ml tip) the mixture was stirred 
by hand for approximately 5 to 10 minutes.  
The concentration of the composite, reported as a mass concentration (g/ml), ranged from 
0.5 to 1 g/ml through-out the whole experiment. The exception being the process and 
manufacturing optimization study, in which only 1 g/ml concentrations were 
systematically studied. In addition to the microparticle concentration, the total amount of 
microparticles influenced the mixing process. Making it difficult to mix extremely low or 
high amounts of composite. Thus, to ensure a facile stirring process roughly 3 ml of 
composite was prepared each time into a single 50 ml plastic container.    
As the composite was mixed and when it appeared to be homogenous it was deemed 
ready. The next step was to either fill syringes with the composite or leave the composite 
to age in the plastic container. Respectively, the filled syringes were stored to be later 
studied by rheological measurements or by conducting an injection test array. The 
syringes were stored horizontally, exposed to ambient light at room temperature. In 
contrast, a portion of the syringes manufactured by the CMO were horizontally stored at 
elevated temperatures (40 °C). 
The composites left to age in the plastic container, were used to study the aging profile 
(i.e. gelation time) of the composite. The gelation time was investigated under three 
different processing conditions: temperature, evaporation, age of the initial silica sol.  
The gelation time was known to be reliant on temperature, hence the gelation was studied 
in room temperature (23 °C) and in refrigerator temperatures (4 °C). Furthermore, in order 
to evaluate the effects of moisture evaporation, the silica-silica composites were set to 
age in both open and closed systems. This meant that the plastic containers were either 
left lidless (open system) or sealed with a lid (closed system). Regarding the open 
systems, each time 200 ml of silica sol was prepared and allowed to age in a 500 ml 
decanter either in room or refrigerator temperatures. Lastly, the age of the initial silica sol 
was also taken into account. Hence, samples were prepared with unaged sol (referred to 
as fresh sols) and aged sols (aged for 1-3 hours). The ultimate aim of these studies were 
to hinder the gelation rate of the composite, so that the syringes could be filled within a 
wider time frame. 
The successful filling of the syringes entailed that the composite remained as a suspension 
for the entire duration of the filling process. Once the composite had gelled, the syringes 
27 
 
 
were next to impossible to be filled. Figure 3.1 depicts a process chart of the whole 
composite preparation process and the studies conducted for the final product. In 
conclusion, the amount of replicate samples and measurements used to study different 
characteristics of the composite are tabularized into Table 3.1. 
Figure 3.1. Flow chart of the composite preparation process and the three different sets 
of studies conducted afterwards. The injection studies aided in defining the appropriate 
needle gauges that could be used to inject the final product. The gel-point evaluation 
study made it possible to optimize the manufacturing process of the composite as well as 
the filling process of the syringes. Lastly, the shelf-life study determined the point-in-time 
when the composite had stabilized inside the syringe – ready to be conventionally stored 
and injected out. 
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Table 3.1. The amount of replicate samples prepared and studied. The brackets referrer 
to the test method used to characterize each property. The measurements included 
oscillatory and viscosity measurements with a rheometer. The injectability study was 
conducted by injecting samples through different needle gauges (25G, 27G and 30G).  
Formulation 
Amount of replicate samples measured                                  
(three replicate measurements per sample) 
Cmp 
(g/ml) 
Sol R-
value 
Gel-point          
(oscillatory) 
Shelf-life           
(oscillatory) 
Shear-thinning 
(viscosity) 
0.5 400 Not measured 3 3 
0.75 400 Not measured 3 3 
1.0 400 3 3 3 
 
Formulation 
Amount of replicate samples injected                                       
(injectability study) 
Cmp 
(g/ml) 
Sol R-
value 
Needle gauge:    
23G 
Needle gauge:                
27G 
Needle gauge:   
30G 
0.5 400 Not injected 1 1 
0.6 400 Not injected 1 1 
0.7 400 Not injected 1 1 
0.75 400 Not injected 1 2 
0.8 400 Not injected 1 1 
0.9 400 Not injected 1 1 
1.0 400 12 18 6 
Cmp = microparticle concentration of the composite sample                                                                            
R-value = H2O:TEOS for the used silica sol 
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3.2.3 Rheological measurements 
A single rotational rheometer (ThermoHaake RS 300, Germany) equipped with a parallel-
plate with a HPP20 TC measuring geometry (D = 20 mm). This system was used to 
measure all materials. A CS/CR rotatory ramp -program with a gap of 0.3 mm and shear 
rate ranging from 0.1000 1/s to 1000 1/s at 25 °C was used to measure viscosity. 
Oscillatory testing was conducted with a frequency sweep with frequency range of 0.01-
10 Hz at 25 °C with a 0.4mm gap.  Furthermore the testing was conducted under 
controlled deformation where the deformation was set to 0.002 which was previously 
determined with an amplitude sweep –program. 
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4. RESULTS AND DISCUSSION 
4.1 Manufacturing process optimization 
During the manufacturing of the silica-silica composite it is paramount to evaluate, 
understand and measure certain process parameters, which are known to either hinder or 
assist the process [19][21]. The parameters investigated in this study were moisture 
evaporation, process temperature and the age of the sol used in the mixing of the 
composite. These were chosen for under inspection, because they could be controlled with 
ease and were known to either increase or decrease the gelation time of the composite. 
The objective was to determine the time frame in which the syringes had to have been 
filled before the composite turned from a low viscosity suspension into a thick gel with 
dominant elastic properties. Thus, after a certain point in time the homogenous filling of 
the syringes would be jeopardized and eventually made next to impossible. Consequently, 
oscillatory measurements were conducted from which a loss tangent (tan δ) was 
calculated for each set of measurements. The loss tangent, explained in Chapter 2.3.3, 
was then used to determine the gel-point and evaluate the strength of the prepared 
composites [50][51]. 
In order to plot data obtained from the oscillation measurements as a function of time, the 
frequency value (range in this study was from 0.01 Hz to 10 Hz) must be set constant. 
The lowest frequency value was chosen so that the possible gel-point could be observed, 
since at higher frequencies viscoelastic materials have a tendency to act stiffer in their 
linear viscoelastic range (see Figure 4.1) [51].  
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Figure 4.1. The composite transitions from a suspension (tan δ > 1) into a gel (tan δ < 
1) after 30 minutes can be observed at 0.01 Hz (single measurement). However, at 0.04 
Hz the same sol-to-gel transition cannot be detected. “Fresh Sol” indicates that an 
unaged silica sol was used and the prefix “O” stands for open system. Mixing began at 0 
min. The reported values represent a single measurement. 
The phenomena observed in Figure 4.1 clearly demonstrates how viscoelastic properties 
are dependent on measurement conditions. If the composite is not subjected to 
appropriately low frequencies, the sol-to-gel transition-point is undetectable. 
Understandably, utilizing even lower frequencies than 0.01 Hz one can gain even more 
accurate data about the material at rest. However, this would greatly increase the 
measurement time. Subsequently, if the measurement procedure takes an excessively long 
time to conduct, the time-dependent viscoelastic properties of the sample may change 
during the measurement [10]. As a result, unreliable data may be obtained. In conclusion, 
the measurement conditions influence the results obtained from oscillatory 
measurements. 
4.1.1 Comparing process temperatures 
The impact of both room (23°C) and refrigerator process temperatures (4-8°C) were 
investigated. All samples investigated in this section, plotted in Figures 4.2, 4.3, 4.4 and 
4.5, were prepared using unaged silica sols (referred to as Fresh Sols) with a microparticle 
concentration of 1 g/ml. Figure 4.2 compares the gelation time of composites 
manufactured in open systems to composites prepared in closed systems both processed 
at room temperatures. Similarly, Figure 4.3 compares these same systems, but at 
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refrigerator temperatures. In conclusion, Figures 4.4 and 4.5 illustrate the gelation time 
differences of similar composites processed at the two different temperatures. 
Figure 4.2. Comparing the effects of minimizing evaporation during processing at 23 °C. 
“Fresh Sol” indicates that an unaged silica sol was used to prepare the composite sample. 
The prefix “O” stands for open system (hollow markers) and correspondingly the prefix 
“C” for closed system (filled markers). Tan δ describes the viscoelastic nature of the 
measured samples. If tan δ > 1, the sample is a suspension, and if tan δ < 1, the sample 
is a gel. Thus, the sol-gel transition point is at tan δ = 1. Mixing began at 0 min. Three 
replicate measurements were conducted from which average values were calculated 
(reported here). 
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Figure 4.3. Comparing the effects of minimizing evaporation during processing at 4-8 
°C. “Fresh Sol” indicates that an unaged silica sol was used to prepare the composite 
sample. The prefix “O” stands for open system (hollow markers) and correspondingly the 
prefix “C” for closed system (filled markers). Tan δ describes the viscoelastic nature of 
the measured samples. If tan δ > 1, the sample is a suspension, and if tan δ < 1, the 
sample is a gel. Thus, the sol-gel transition point is at tan δ = 1. Mixing began at 0 min. 
Three replicate measurements were conducted from which average values were 
calculated (reported here). 
The gelation time can be understood as the first measuring point where tan δ < 1. 
Accordingly, the gelation of the composite in room temperature is observed to occur in 
less than 60 minutes regardless of minimizing evaporation (see Figure 4.2), but with lower 
temperatures the gelation is witnessed to occur after the 120 min mark (see Figure 4.3). 
The syringes could arguably still be filled near the vicinity of the gel-point, since the 
composite could be pipetted from the sample container on to the rheometer plate with 
relative ease. Ultimately, the flow characteristics of the composites drastically changed 
once the storage modulus of the composite had reached 100 000 Pa (at 0.01 Hz). At this 
point the composite was difficult to pipette, because  it no longer flowed as single 
droplets, but as a continuous elastic fluid rapidly thickening into a rigid gel (G´ ≈ 
1 000 000 Pa).   
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Figure 4.4. Comparing the effects of lowering the process temperature from 23°C to 4-
8°C for open systems (prefix “O”). Tan δ describes the viscoelastic nature of the 
measured samples. If tan δ > 1, the sample is a suspension, and if tan δ < 1, the sample 
is a gel. Thus, the sol-gel transition point is at tan δ = 1. Mixing began at 0 min. Three 
replicate measurements were conducted from which average values were calculated 
(reported here). 
As is evident from Figure 4.4 and 4.5 that lowering the process temperature increases the 
gelation time of the composite. Resulting in a wider filling time frame of syringes. 
Although, lower temperatures inherently tend to increase a materials viscosity [51], in 
this case the viscosity increase was subtle and did not pose any problems during 
measurements.          
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Figure 4.5. Comparing the effects of lowering the process temperature from 23°C to 4-
8°C for closed systems (prefix “C”). Tan δ describes the viscoelastic nature of the 
measured samples. If tan δ > 1, the sample is a suspension, and if tan δ < 1, the sample 
is a gel. Thus, the sol-gel transition point is at tan δ = 1. Mixing began at 0 min. Three 
replicate measurements were conducted from which average values were calculated 
(reported here).  
The process temperature seems to have a greater influence on the gelation time of the 
composite than controlling the amount of water evaporating during the process. However, 
this correlation is insubstantial, because the evaporation surfaces were relatively small, 
whereas the temperature difference was relatively large. Nevertheless, it is certain that 
optimal conditions for retarding the gelation time of the composite is achieved by keeping 
process temperatures in the range of 4-8°C and minimizing evaporation of moisture.       
4.1.2 Comparing aged and unaged silica sols 
It was postulated that manufacturing the silica composites from aged silica sols would 
decrease the gelation time of the composite [44]. Consequently, constricting the time 
frame in which the syringes could be homogenously filled. The postulation was found to 
be true. Figures 4.6, 4.7 and Table 4.1 compare the effects of using aged sols in the 
composite manufacturing process. The term “Fresh sol” indicates that sol had not been 
allowed to age prior to manufacturing, whereas the prefixes “1 h Sol”,”2 h Sol” and “3 h 
Sol” specify the age of the sol used. Respectively, the initial silica sols were aged for 1, 2 
and 3 hours. The prefixes “O” and “C” anterior to the process temperatures stand for open 
and closed systems, analogous. 
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 Table 4.1. The values were measured at a frequency of 0.01 Hz. The circled area values 
indicate the time frame in which the gelation of the composite samples occurred. The gel-
point being at tan δ = 1. Mixing began at 0 min. Three replicate measurements were 
conducted from which average values were calculated (reported here).  
 
When preparing the composites with sols aged for 1 to 2 hours the gelation of the 
composite is observed to occur within the first 30 minutes of the manufacturing procedure 
(Table 4.1). However, when composites are prepared with fresh sols the gelation is 
observed to occur between 30 to 60 minutes (Table 4.1). Remarkably, no gel-point was 
observed for composites prepared with 3 hour old sols (Table 4.1). This indicates that the 
gelation occurred within the first 15 minutes. Moreover, within 90 minutes the composites 
prepared from aged silica sols thickened into a rigid paste-like gel, which could no longer 
be aptly measured. Thus, no rheological measurements could be conducted for the “1 h 
Sol”-, “2 h Sol”- and “3h Sol”-samples at the 90 minute mark.  
 
 Fresh Sol O23°C 1 h Sol O23°C 2 h Sol O23°C 3 h Sol O23°C 
Time G' (Pa) tan δ G' (Pa) tan δ G' (Pa) tan δ G' (Pa) tan δ 
15 min 592 1.268 1 214 1.272 1 771 1.468 12 258 0.660 
30 min 1637 1.275 14 400 0.276 21 200 0.226 27 041 0.734 
60 min 65 720 0.506 189 700 0.740 254 900 0.629 130 900 0.455 
90 min 401 200 0.163 - - - - - - 
Circled area = the occurrence of the sol-to-gel transition  
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Figure 4.6. Comparison of composites prepared from aged sols with composites prepared 
from fresh (i.e. unaged) sols. The composite samples were aged in refrigerator 
temperatures as open systems. Tan δ describes the viscoelastic nature of the measured 
samples. If tan δ > 1, the sample is a suspension, and if tan δ < 1, the sample is a gel. 
Mixing began at 0 min. Three replicate measurements were conducted from which 
average values were calculated (reported here). 
.   
Figure 4.7. Comparison of composites prepared from aged sols with composites prepared 
from fresh (i.e. unaged) sols. The composite samples where then aged in refrigerator 
temperatures as closed systems. Tan δ describes the viscoelastic nature of the measured 
samples. If tan δ > 1, the sample is a suspension, and if tan δ < 1, the sample is a gel. 
Mixing began at 0 min. Three replicate measurements were conducted from which 
average values were calculated (reported here). 
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The age of the initial silica sol has a great impact on the gelation time of the composite, 
which can be seen in Figures 4.6 and 4.7. Regarding open process systems at refrigerator 
temperature, composites manufactured with aged silica sols were detected to gel 
approximately 60 minutes faster than composites prepared with unaged sols (Figure 4.6). 
This difference was even greater under closed process conditions (at 4°C), where a 90 
minute difference in the gelation time was witnessed (Figure 4.7). Consequently, the 
homogeneity of the final product may be compromised, by simply neglecting to use 
unaged silica sols during manufacturing. Even if the sol is allowed to age for an hour (at 
23 °C) prior to mixing the composite, the homogeneity of the final product is jeopardized.  
As the silica sol ages, condensation reactions polymerize the silica to form larger 
particles, particle chains and agglomerates [19][21]. Ultimately, forming the initial 
suspension into a three-dimensional gel. This polymerization process is accelerated by 
the addition of the silica microparticles, which simultaneously act as nucleating agents in 
the condensation process and as particle-reinforcements in the gel [52, p. 14-15]. For this 
reason, the silica sol on its own transforms into a gel more slowly than the silica sol 
microparticle mixture. Successively, the composites gel transformation is dependent on 
the polymerization degree of the initial silica sol. Table 4.1 illustrates this phenomena 
well, which shows that the gelation time of the composite decreases as the silica sols 
gradually age.  
4.2 Shelf-life study 
After the silica-silica composite is processed and the syringes are successfully filled. The 
next logical step is to evaluate the shelf-life of the final product. This was done by 
conducting an injection test array through various needle sizes and oscillatory 
measurements to witness, if any gel structure deterioration had occurred over time. In this 
circumstance, the shelf-life studies included determining whether the final product would 
remain stable (i.e. homogenous) for two months and to study the effects of elevated 
storage temperatures (40 °C). Furthermore, product samples were prepared with varying 
microparticle concentrations (0.5, 0.75 and 1.0 g/ml) in order to evaluate how the 
microparticle concentration might affect the shelf-life of the product. Naturally, as the 
microparticle concentration is decreased the cross-linking density of the gel structure 
decreases. As a results, the structure of the silica-silica composite becomes more fragile 
[53][54]. During preliminary injection testing, it was witnessed that products with a 
microparticle concentration lower than 0.5 g/ml could not withstand the injection process 
and visible phase separation occurred.  
In addition, the time-frame in which the composite became stable inside the syringe was 
determined. Only after the composite had stabilized inside the syringe, the structure of 
the composite could withstand the injection process (entails high shear stresses). 
Therefore, this stability experiment was conducted by injecting varyingly aged 
composites through 23G and 27G needles to see how much time the composite needed to 
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stabilize. For the first twelve hours of this follow-up, measurements were conducted in 
one hour intervals and then in 24 hour intervals continuously up to a month.   
4.2.1 Viscoelasticity of the composites 
Once the syringes had been filled, the progressive gelation of the composite within the 
syringe was mapped utilizing rheological measurements under small angle oscillatory 
shear. The objective was to determine the point-in-time when the gelation process was 
complete and whether the composite remained homogenous during the whole study [51]. 
The results for 1 g/ml samples are presented in Figure 4.8, whereas Figure 4.9 presents 
the results for 0.5 g/ml and 0.75 g/ml samples.  
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Figure 4.8. The two graphs represent measured viscoelastic properties as a function of 
time at two different frequencies: 0.01 Hz (graph A) and 10 Hz (graph B). The samples 
had a microparticle concentration of 1 g/ml. The plotted values are averages of nine 
replicate measurements from three replicate samples. The x-axis designates the time 
which has passed from the point when the syringes were filled.  
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Figure 4.9. The effects of lowering the microparticle concentration of the composites 
under 1 g/ml was studied under two frequencies: 0.01 Hz (graph A) and 10 Hz (graph B). 
The plotted values are averages of nine replicate measurements from three replicate 
samples. The x-axis designates the time which has passed from the point when the 
syringes were filled. 
As was expected, the microparticle concentration had an effect on the viscoelastic 
properties of the composite, because the microparticles in fact reinforce the gel-structure 
of the composite [52]. Therefore, as the microparticle volume concentration is decreased, 
the storage modulus (G’) of the composite decreases (Figure 4.9).  
In addition to affecting the elastic dominance of the composite, the microparticle 
concentration also affects the gelation time of the composite. This phenomena is apparent 
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from Figure 4.9, where the G’ values of the samples are seen to stabilize within different 
time periods, according to their microparticle volume concentration. The term 
“stabilization” is to be understood as the point-in-time where the viscoelastic properties 
(G´, G´´ and tan δ) begin to plateau (seen in Figures 4.8 and 4.9). Nonetheless, lowering 
the microparticle concentration of the composites appear to slightly impede the 
stabilization of the composite. This aspect must be taken into account when 
manufacturing the composite syringes to prevent particle sedimentation. Thus, to ensure 
that the composite inside the syringes remain homogenous, after the filling, the syringes 
are to be subjected to a rotational motion (e.g. with a tube rotator). This motion must be 
kept at least till the composite has stabilized, in a way, that the microparticles are 
suspended in the gel and can no longer migrate. After the composite has stabilized it can 
be stored conventionally in static conditions without its structural integrity being 
jeopardized. However, understandably this integrity is lost over time. Therefore, it was 
important to evaluate how the composite retained its viscoelastic properties over time.      
The samples were seen to retain their viscoelastic properties for at least a month, even at 
high frequencies, since no drastic increases or decreases in the measured moduli values 
are observed in neither Figure 4.8 nor Figure 4.9. For example, a sudden increase in tan 
δ (i.e. tan δ > 1) values would have indicated that the three-dimensional structure of the 
composite had reverted back to its initial two-dimensional network. The weak chemical 
bonds between the silica macromolecules could have been dissipated by internal and/or 
external forces (e.g. shear stress, thermal energy) resulting in the depolymerization of the 
composite. In contrast, a sudden increase could indicate the onset of polymer aging (i.e. 
cross-linking of the macromolecules). This aging process would initially harden and 
increase the mechanical properties of the composite. Ultimately making the product 
brittle and susceptible to the formation of cracks and crevices. The aging process is caused 
by chemical transformation of macromolecules and is often initiated and meditated by 
exposure to extreme weather conditions (e.g. UV-light, ozone,) and/or oxidative 
chemicals (e.g. hydroperoxides) [55].Therefore, under controlled storage conditions the 
latter scenario is unlikely to occur in the silica-silica composite matrix. 
Most likely the silica-silica composite will eventually depolymerize and regress back to 
a viscous fluid rather than developing dominant elastic properties. This statement is 
supported by the results denoted in Table 4.2. The samples studied in Table 4.2 are 
identical to the samples studied in Figure 4.8 in respect to their formula. However, the 
samples were manufactured by the CMO and the syringes used were made of glass instead 
of plastic. For this reason the CMO manufactured tips of the syringe were not cut off prior 
to the oscillatory measurements. Thus, preceding the measurements the CMO samples 
were subjected to shear stresses leading to the shear-thinning of the samples. As a result, 
the measured absolute values for G´ and G´´ are a magnitude lower for the samples in 
Table 4.2 compared to the samples investigated in Figure 4.8.   
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Table 4.2. The CMO manufactured syringes. Sample R4001 was the reference sample, 
R4002A was stored for 1 month in room temperature and R4003A for 2 months. 
Consequently R4002B was stored for 1 month and R4003B for 2 months with the 
exception of being stored in elevated temperatures (40 °C). The values of the variables 
were measured at a frequency of 0.01 Hz. The reported values are average values of three 
replicate measurements. 
 
The final silica-silica composite product cannot withstand temperatures above ambient 
temperatures for an extended period of time during storage, and should therefore be stored 
in a temperature controlled environment. This is evident when comparing the viscoelastic 
properties of the samples tabulated in Table 4.2. Furthermore, the tabularized data 
supports the visual observations made during the oscillatory measurements: the samples 
stored in 40°C were observed to be flowing fluids as supposed to resembling solid-like 
gels. This factor could pose a significant problem when transporting and respectively 
storing the product in countries with a tropical climate. In addition, to deteriorating in 
elevated temperatures, the silica-silica composites seem to lose some of their elastic 
strength within the first 2 months after being stored at room temperature. This aspect can 
be seen in Table 4.1, but is further highlighted in Table 4.2. The represented data (Table 
4.2) compares the measured viscoelastic properties of R4002A- and R4003A-samples in 
the entire frequency range used to study the materials. 
 
 
 
Sample Storage time G' (Pa) G'' (Pa) tan δ 
R4001 Unaged 189 867 83 757 0.445 
R4002A 1 month 181 167 81 323 0.450 
R4003A 2 months 68 830 35 280 0.513 
R4002B 1 month (40°C) 34 30 0.777 
R4003B 2 months (40°C) 48 50 1.259 
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Table 4.3. The CMO manufactured syringes. Both samples were stored in room 
temperature. Sample R4002A was stored for a month, whereas sample R4003A was stored 
for 2 months before they were measured under small angle oscillatory shear. The reported 
values are average values of three replicate measurements. 
 
It is apparent that the measured G´ values at the two month time-period are approximately 
half of what they are for the samples stored for a period of one month, regardless of the 
subjected frequency (see Table 4.3). However, no distinctive visual observations could be 
made between the two samples as they seemed to have similar viscoelastic properties. 
Meaning, that the samples should be, at some point, studied by injecting them through 
thin needles in order to evaluate, if a difference in terms of injectability exist between 
them. The injection studies would also aid in determining whether the two month sample 
is actually unusable. This distinction cannot be made simply by stating that the G´ values 
plummet within 2 months after being manufactured. In conclusion, the final silica-silica 
composite product should be stored and kept in ambient temperatures to ensure an 
extended shelf-life. 
4.2.2 Injectability of the composites 
The composites aging process was investigated by conducting injection studies through 
two needle gauges (23G and 27G). In order to support and further focus the observations 
 Sample R4002A Sample R4003A 
Hz G' (Pa) G'' (Pa) tan δ G' (Pa) G'' (Pa) tan δ 
0,01 181 167 81 323 0.450 68 830 35 280 0.513 
0,04 289 933 66 563 0.225 114 500 20 790 0.182 
0,07 308 100 77 353 0.250 123 333 25 013 0.203 
0,1 327 333 53 367 0.158 120 300 22 390 0.186 
0,4 353 633 29 473 0.085 139 200 22 913 0.164 
0,7 358 133 19 391 0.054 146 600 15 747 0.106 
1 356 700 12 074 0.036 149 433 12 199 0.081 
4 361 533 25 220 0.072 154 833 14 177 0.091 
7 335 033 37 400 0.106 157 933 11 882 0.075 
10 367 033 15 940 0.048 152 667 12 880 0.084 
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made from the small angle oscillatory shear studies. The results have been tabularized 
into Tables 4.4 and 4.5.  
Table 4.4.  Composites with microparticle concentrations of 1 g/ml were injected through 
thin needles (23G and 27G). The storage time indicates the age of the composite syringe 
before it was injected (calculated from when the syringe was filled). 
 
 
 
 
 
Storage 
time 
Syringe 
# 
23G 27G Observations 
1 h 1. ― 1000 µl* 
Not gelled, phase separation 
2 h 1. ― 1000 µl* 
Not gelled, phase separation 
3 h 1. ― 1000 µl* 
Not gelled, phase separation 
4 h 1. 800  µl** 200 µl* 
Weak Gel, little separation 
5 h 1. 600 µl** 400 µl* 
Weak Gel, little separation 
6 h 1. 500 µl** 500 µl* 
Gel, close to final product 
7 h 1. 900 µl** 100 µl* 
Stable Gel 
 2. 300 µl** 600 µl* 
Stable Gel 
8 h 1. 1000 µl* ― 
Stable Gel 
 2. ― 1000 µl* 
Stable Gel 
*   The amount of composite successfully injected through the needle (out of 1000 µl). 
** The composite was first injected through a 27G needle and then the rest was injected     
      through a 23G needle 
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Table 4.5. Composites with microparticle concentrations of 1 g/ml were injected through 
thin needles (23G and 27G). The storage time indicates the age of the composite syringe 
before it was injected (calculated from when the syringe was filled).   
 
Storage 
time 
Syringe 
# 
23G 27G Observations 
24 h 1. 1000 µl* ― 
 
§ 
All composites injected 
were stable gels meaning no 
phase separation was 
observed. 
§ 
Only small amounts of fluid 
is leeched out from the 
composite after it has been 
injected unto thin tissue 
paper. 
§ 
The final product resembles 
a smooth and matte paste. 
 2. ― 1000 µl* 
 3. ― 700 µl* 
 4. ― 700 µl* 
48 h 1. 1000 µl* 1000 µl* 
 2. ― 1000 µl* 
96 h 1. 1000 µl* ― 
 2.   
120 h 1. 1000 µl* ― 
 2. ― 900 µl* 
144 h 1. 1000 µl* ― 
 2. ― 1000 µl* 
 3. ― 1000 µl* 
168 h 1. 1000 µl* ― 
 2. ― 1000 µl* 
*   The amount of composite successfully injected through the needle (out of 1000 µl). 
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According to the injectability data in Table 4.4 the silica-silica composite (c = 1 g/ml) 
should not be injected within the first seven hours of being filled, because the composite 
cannot withstand the forces applied to it upon the injection process. This observation 
designates that even though the samples G´ values are seen to stabilize within three hours 
(see Figure 4.8) the formation of the three-dimensional gel structure of the composite is 
not completely finished by this time. It is most likely, that the subtle progression of the 
elastic properties of the composite cannot be witnessed by the rheological setup used in 
this study. Nonetheless, the key information is that at least for the first eight hours of 
being filled, the syringes should be subjected to a rotational motion in order to prevent 
microparticle sedimentation. After this procedure the syringes can be stored 
conventionally. This statement is further supported by comparing the injectability data of 
Tables 4.4 and 4.5: the injectability through a 27G needle improves after the first eight 
hours of being filled.  
The final objective was to determine whether it was possible to successfully inject the 
silica-silica composite through a 30G needle. This was hypothesized to be extremely 
difficult due to the size of the silica microparticles. After preliminary injection tests, no 
composites with a particle concentration of 1 g/ml were successfully injected through a 
30G needle. In this context, a successful injection entailed that the whole sample volume 
could be injected through the 30G needle. The whole volume in this case being 1000 µl. 
After the failed injections, it was apparent that the particle concentration should be 
lowered below 1 g/ml. Consequently another array of composite syringes, with 
concentrations ranging from 0.5 to 0.9 g/ml, were prepared to be injected through very 
fine needles. The obtained data is tabularized in the Table 4.6. 
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Table 4.6. Composites with different microparticle concentrations were injected through 
27G and 30G needles. The composite syringes were injected after 7 days had passed from 
the day they were filled. Visual observations of the injected composites are also described 
in order to further characterize the composites. 
 
Lowering the microparticle concentrations can pose problems regarding the stability of 
the final product. In other words, as the microparticle concentration is decreased, the 
composite mechanical properties weaken. As a result, the inherent ability of the composite 
to withstand shear stresses and strains decreases. Thus, composites with a lower 
microparticle concentration are more shear-thinning than composites with a higher 
concentration (Figure 4.10). 
Microparticle 
concentration 
Needle gauge 
Amount injected 
(out 1000 µl) 
Observations 
0.5 g/ml 27 G 1000 µl 
Phase separation occurred – 
extremely weak gel 
 30 G 200 µl 
0.6 g/ml 27 G 1000 µl 
Phase separation occurred – 
weak gel 
 30 G 600 µl 
0.7 g/ml 27 G 1000 µl Successful injections, 
although tiny visible 
clusters present  30 G 1000 µl 
0.75 g/ml* 30 G 1000  µl Resembles “1 g/ml”- sam-
ples: stabile gel 
 30 G 1000  µl 
0.8 g/ml 27 G 200 µl 
Resembles “1 g/ml”-
samples: stabile gel 
 30 G 200 µl 
0.9 g/ml 27 G 1000 µl 
Highly resembles “1 g/ml”-
samples 
 30 G 100 µl 
* The samples were stored for a period of 30 days before they were injected whereas 
the other samples (with different concentrations) were stored for 7 days. 
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Figure 4.10.  Shear thinning becomes progressively larger as the volume concentration 
of the solid silica microparticles decreases. The legend shows each sample’s storage time 
and microparticle concentration. 
In spired by the data gathered in Table 4.6 and in Figure 4.9, composites with a 
microparticle concentrations of 0.75 g/ml were prepared. After being stored for a period 
of one month, the 0.75 g/ml composites were injected through thin needles (see Table 
4.6). As a result, two out two of the prepared samples were successfully injected through 
30G needles. In conclusion, if the soul objective is to manufacture a silica-silica 
composite that could be injected through a 30G needle, composites owning a 
microparticle concentration between 0.7-0.75 g/ml would be the most prominent to 
investigate further. 
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5. CONCLUSIONS 
Suspending silica gel microparticles in a sol-gel derived silica hydrogel offers a promising 
alternative to parenterally administered organic drug delivery systems. The benefits of 
encapsulating therapeutic agents within sol-gel derived silica microparticles have been 
discussed in several other reports [17][18][23][24][34][45]. 
The objective of this study was to manufacture syringes with an injectable silica-silica 
composite and to study its processing methods, injectability and shelf-life. The composite 
in itself is a shear-thinning material and the viscosity of the composite increases, to a 
certain degree, as a function of time. This meant that once the composite had been mixed, 
the syringes were to be filled before the composite turned into a thick gel. This ensured 
that the syringes could be homogeneously filled and that the composite would gradually 
gel inside the syringes – suspending the silica microparticles in place.  
The shear-thinning characteristic of the composite allows the composite gel to be injected 
through even particularly thin needles (e.g. needles suitable for intraocular administra-
tion). Naturally, this shear-thinning property progressively decreases as the volume con-
centration of solid particles within the composite is increased or as the R-value of the 
silica hydrogel is decreased. It is to be noted that in this study the R-value for the silica 
hydrogel was a constant R400 and the effects of lowering the R-value was not investi-
gated. Another noteworthy aspect is that by decreasing the microparticle concentration 
the structure of the composite becomes weaker in terms of mechanical strength. The rea-
son is that the microparticles act as reinforcing agents stabilizing the hydrogel matrix. As 
a result, weak composites cannot withstand the injection process (i.e. the composite is too 
shear-thinning). 
Before any injection studies were conducted, it was necessary to closely examine the 
manufacturing process of the composite in order to ensure the production of a viable final 
product. In this context, a final product is defined as a 1 ml syringe filled with a composite 
owning a 1 g/ml silica microparticle concentration. Accordingly, the gelation process of 
the composite was characterized under small angle oscillatory shear to create a process 
timeline. The results indicated that by lowering the process temperature to 4-8°C from 
room temperatures (23°C), the gelation process was considerably hindered. This resulted 
in a broader time frame in which the syringes could be homogeneously filled. In addition 
to temperature effects, evaporation and the age of the silica sol (with a pH of 6.2) used in 
the manufacturing process were also studied. Since the sample sizes and the evaporation 
surfaces were relatively small, evaporation did not seem to greatly influence the gelation 
process. In contrast, using unaged silica sols to mix the composite had a greater impact 
than striving to minimize the amount of evaporation taking place during the process. The 
optimal processing conditions defined by a broad filling-time frame were achieved by 
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utilizing fresh sols (sol age < 1 hour), closed process systems (i.e. closed containers, 
flasks, etc.) and employing refrigerator temperatures (4-8°C). Under these conditions the 
syringes could be filled within the first 210 minutes. This time was calculated from the 
point when the two separate components of the composite were mixed together. In con-
trast, composites prepared in room temperature had to have been filled within the first 60 
minutes. The point-in-time when the syringes could no longer be filled was determined 
by a visual observation: the composite was witnessed to flow ineptly as a single elastic 
fluid and not as a droplet forming liquid. The same point may also be characterized by a 
G´ value of 100 000 Pa measured at a frequency of 0.01 Hz.  
Once the syringes were successfully filled, the composite stabilized inside the syringes 
within the first 8 hours. Meaning that, after this point-in-time the product could be in-
jected through a fine needle in a way that its physical structure was not compromised in 
the process. Therefore, as soon as the syringes were filled they should be subjected to a 
rotational motion to avoid any particle sedimentation from occurring. Once the micropar-
ticles can no longer migrate inside the composite matrix, the product can be safely stored 
conventionally in static conditions.  
Upon storage, the composite was observed to preserve its viscoelastic properties for a 
duration of 30 days as was the case with the syringes manufactured by the CMO. Regard-
ing the injectability studies, composites owning a 1 g/ml microparticle concentration were 
systematically injected through 23G needle in a way that the whole sample volume (1 ml) 
was successfully injected through. As the needle size was decreased to 27G and 30G, the 
amount of successful injections also decreased. Approximately two thirds of the samples 
injected through a 27G needle were successfully injected out. In contrast, with the 30G 
needles, every injection attempt was unsuccessful. However, by decreasing the micropar-
ticle concentration from 1 g/ml to 0.75 g/ml the composites injectability through 30G 
needles significantly improved without jeopardizing the composites viscoelastic charac-
teristics. These are promising preliminary results, which should be investigated more 
thoroughly in the future. 
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